![Kathryn Romano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathryn Romano
Comptroller/Controller/Auditor at
KRYSTAL BIOTECH, INC.
Net worth: 7 M $ as of 30/05/2026
Profile
Kathryn A. Romano is currently Chief Accounting Officer & Executive VP at Krystal Biotech, Inc. since 2020.
Formerly, Ms. Romano was Controller at CNX Resources Corp.
from 2018 to 2019 and Controller at Rice Energy, Inc. from 2013 to 2017.
Ms. Romano completed undergraduate studies at The Pennsylvania State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/03/2026 | 22,366 ( 0.08% ) | 7 M $ | 30/05/2026 |
Kathryn Romano active positions
| Companies | Position | Start |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Comptroller/Controller/Auditor | 19/01/2020 |
Former positions of Kathryn Romano
| Companies | Position | End |
|---|---|---|
| CNX RESOURCES CORPORATION | Comptroller/Controller/Auditor | 30/11/2019 |
| RICE ENERGY INC | Comptroller/Controller/Auditor | 31/10/2017 |
Training of Kathryn Romano
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
CNX Resources Corp.
 CNX Resources Corp. Oil & Gas ProductionEnergy Minerals Develops and explores NGLs, natural gas & oil projects | Energy Minerals |
Rice Energy, Inc.
 Rice Energy, Inc. Integrated OilEnergy Minerals Engages in the acquisition, exploration and development of natural gas and oil properties | Energy Minerals |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
- Stock Market
- Insiders
- Kathryn Romano
